NSCLC
Conditions
Interventions
by 
analysis 
(panel 
detection, 
and 
protein 
analysis) 
of 
markers 
find 
Sponsors
Department of Thoracic Surgery, Xinqiao Hospital, The Army Military Medical University, Chongqing
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with stage I-IIA NSCLC or benign pulmonary nodules as confirmed by surgery and pathology; 2. Nodules of 8 mm to 3 cm in size (solid and mixed nodules predominate, with a small amount of pure ground-glass nodules); 3. With a resection of lung nodules scheduled; 4. Initial diagnosis without receiving any tumor-specific treatment; 5. Agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with a history of bone marrow or cell transplantation; 3. Patients with other concurrent tumors; 4. Patients with tumor recurrence; 5. Patients with a history of allogeneic blood transfusion within recent 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target gene capture and sequencing;DNA methylation sequencing;cytokine measurement;folate receptor folate receptor; | — |
Countries
China
Contacts
Public ContactJigang Dai
Department of Thoracic Surgery, Xinqiao Hospital, The Army Military Medical University, Chongqing
Outcome results
None listed